Page last updated: 2024-08-24

iridium radioisotopes and Cancer of Prostate

iridium radioisotopes has been researched along with Cancer of Prostate in 120 studies

Research

Studies (120)

TimeframeStudies, this research(%)All Research%
pre-19907 (5.83)18.7374
1990's23 (19.17)18.2507
2000's57 (47.50)29.6817
2010's29 (24.17)24.3611
2020's4 (3.33)2.80

Authors

AuthorsStudies
Chang, AJ; Frank, CH; Kishan, AU; Lyu, Q; Park, SJ; Ramesh, P; Ruan, D; Sheng, K; Venkat, PS1
Buchser, D; Cacicedo, J; Casquero, F; Espinosa, J; Gomez-Iturriaga, A; Gonzalez, A; Martinez-Indart, L; Mayrata, E; Minguez, P; Perez, F; San Miguel, I; Suarez, F1
Fu, Z; Jiang, C; Jiang, Y; Liu, T; Qin, W; Shi, K; Sun, Q; Wang, F; Wu, P; Ye, Z1
Arnau, GM; Caramia, F; Gamell, C; Gulati, T; Haupt, Y; Huang, C; Keam, SP; Kleifeld, O; Neeson, PJ; Schittenhelm, RB; Williams, SG1
Enger, SA; Keyes, R; Mao, X; Pineau, J1
Davis, IR; Dayes, IS; Gilbert, J; Julian, JA; Levine, MN; Parpia, S; Sathya, J1
Bucci, J; Cutajar, D; Guatelli, S; Howie, A; Petasecca, M; Poder, J; Rosenfeld, A1
Beyer, B; Carl, CO; Frenzel, T; Graefen, M; Krüll, A; Löser, A; Löser, B; Nagaraj, Y; Petersen, C; Schwarz, R1
Hannoun-Lévi, JM; Peiffert, D1
Karimi Jashni, S; Mahdavi, SR; Meigooni, AS; Safigholi, H; Sardari, D1
Alonzi, R; Bryant, L; Hoskin, P; Hughes, R; Lowe, G; Ostler, P; Rojas, A1
Adams, QE; Breitbach, EK; Enger, SA; Flynn, RT; Kim, Y; Li, X; Rockey, WR; Wu, X; Xu, J1
Boladeras, A; Díaz, A; Ferrer, F; Guedea, F; Gutierrez, C; Martinez, E; Pera, J; Pino, F; Polo, A; Santorsa, L; Suarez, JF1
Alonzi, R; Dankulchai, P; Díez, P; Hoskin, PJ; Hughes, R; Lowe, G; Mullassery, V; Ostler, P1
Gotovchikova, MY; Iliin, ND; Kanaev, SV; Novikov, RV; Novikov, SN1
Garmash, SV; Isaev, TK; Kravtsov, IB; Panshin, GA; Pavlov, AY; Solodky, VA; Tsybulsky, AD1
Franich, RD; Haworth, A; Millar, JL; Panettieri, V; Smith, RL1
Beld, E; Lagendijk, JJ; Moerland, MA; Seevinck, PR; Viergever, MA1
Gustafson, GS; Krauss, DJ; Limbacher, A; Martinez, AA; Mitchell, B; Sebastian, E; Ye, H1
Furukawa, S; Hoshino, Y; Katoh, H; Kurotaki, K; Nakano, T; Noda, S; Suzuki, Y1
Chiang, PH; Fang, FM; Huang, HY; Wang, CJ; Wang, YM1
Boda-Heggemann, J; Ehmann, M; Hermann, B; Köhler, FM; Küpper, B; Lohr, F; Riesenacker, N; Wenz, F; Wertz, H1
Choo, R; Furutani, KM; Gold, DG; Hebl, JR; Macdonald, OK; McLaren, RH; Mynderse, LA; Pisansky, TM; Wilson, TM1
Boreham, D; Dayes, IS; Julian, J; Sathya, J; Schnarr, K1
Baba, S; Hayakawa, K; Ishiyama, H; Kitano, M; Kotani, S; Matsumoto, K; Okusa, H; Satoh, T; Tabata, K; Uemae, M1
Ares, C; Bieri, S; Dipasquale, G; Khan, H; Miralbell, R; Nouet, P; Ozsoy, O; Pampallona, S; Popowski, Y; Rouzaud, M1
Anton, M; Hackel, T; Hermann, RM; Hess, CF; Selbach, HJ; Vorwerk, H; Wagner, D1
Demanes, J; Ghilezan, M; Gustafson, GS; Martinez, AA; Schour, L; Vargas, C1
Izumi, K; Konaka, H; Kumano, T; Mizokami, A; Namiki, M; Narimoto, K; Nohara, T; Shigehara, K; Yasuhide, K; Yoshifumi, K1
Ghilezan, M; Gonzalez, J; Gustafson, G; Kernen, K; Kestin, L; Krauss, D; Martinez, AA; Shetty, S; Vicini, F; Ye, H1
Dumas, I; Haie-Meder, C; Martelli, H; Mazeron, R; Oberlin, O1
Akimoto, T; Ebara, T; Ishikawa, H; Ito, K; Kato, H; Miyakubo, M; Nakano, T; Okamoto, M; Suzuki, K; Takahashi, T; Tamaki, T; Yamamoto, T1
Bryant, L; Cladd, H; Hoskin, P; Hughes, R; Lowe, G; Milner, J; Ostler, P; Rojas, A1
Coalter, G; Haughey, A; Mugabe, K1
Kropf, S; Lüdemann, L; Mohnike, K; Ricke, J; Seidensticker, M; Wust, P; Wybranski, C1
Fujii, T; Hara, R; Hiratsuka, J; Jo, Y; Miyaji, Y; Nagai, A; Yoden, E; Yokoyama, T1
Lilleby, W; Raabe, NK; Tafjord, G1
Budiharto, T; Corn, BW; Davits, RJ; de Kruijf, WJ; Haustermans, K; Hol, S; Neustadter, D; Oyen, R; Poortmans, PM; Van den Bergh, L; Venselaar, JL; Verstraete, J; Wijsman, BP1
Borroni, M; Carrara, M; Cerrotta, A; Fallai, C; Gambarini, G; Grisotto, S; Maucione, A1
Djukic, V; Eble, MJ; Heidenreich, A; Holy, R; Klotz, J; Pfister, D; Pinkawa, M; Piroth, MD1
Enger, SA; Fisher, DR; Flynn, RT1
Gabor, S; Hackl, A; Mayer, R; Prettenhofer, U; Stranzl, H; Wurzinger, G1
Gonzalez, J; Gustafson, G; Kearney, D; Kestin, L; Martinez, A; Spencer, W; Vicini, FA1
Dokiya, T; Momma, T; Saito, S; Yorozu, A1
Brenner, PC; Cross, P; Duval, PJ; Jagavkar, RS; Kooner, R; Martland, J; O'Neill, GF; Saalfeld, J; Stevens, MJ; Stricker, PD1
Anagnostopoulos, G; Baltas, D; Baras, P; Karaiskos, P; Kipouros, P; Kozicki, M; Papagiannis, P; Sakelliou, L; Sandilos, P; Seimenis, I1
Anagnostopoulos, G; Baltas, D; Geretschlaeger, A; Martin, T; Papagiannis, P; Tselis, N; Zamboglou, N1
Lee, WR; Moughan, J; Owen, JB; Zelefsky, MJ1
Hirokawa, Y1
Chiang, PH; Chuang, YC; Fang, FM; Jong, WC; Wang, HJ; Yu, TJ1
Dogan, N; Glasgow, GP; Mohideen, N1
Fujisawa, M; Hiratsuka, J; Imajo, Y; Jo, Y; Nagase, N; Yoshida, K1
Bucci, J; Duggan, L; Kron, T1
Brandberg, Y; Häggarth, L; Hellström, M; Nilsson, S; Wahlgren, T1
Fujii, T; Fujisawa, M; Hiratsuka, J; Jo, Y; Takenaka, A1
Brinkmann, DH; Davis, BJ; Herman, MG; Kline, RW; Kruse, JJ; LaJoie, WN; Pisansky, TM; Schwartz, DJ1
Chawla, R; Joneja, OP; Popowski, Y; Zilio, VO1
Cosset, JM; Mettler, F; Pinillos-Ashton, L1
Deneufbourg, JM; Lenaerts, E; Nickers, P; Thissen, B1
Bertermann, H; de la Rosette, JJ; Hammer, J; Kolkman-Deurloo, IK; Kovács, G; Loch, T; Pötter, R1
Khaksar, SJ; Laing, RW; Langley, SE1
Akimoto, T; Ito, K; Kashiwagi, B; Katoh, H; Nakano, T; Noda, SE; Yamamoto, T1
Akimoto, T; Harashima, K; Ito, K; Nakano, T; Nakayama, Y; Niibe, H; Noda, SE; Saitoh, J; Sakurai, H; Suzuki, K; Yamamoto, T1
Deneufbourg, JM; Jansen, N; Nickers, P; Thissen, B1
Asadpour, B; Borchers, H; Eble, MJ; Fischedick, K; Gagel, B; Jakse, G; Pinkawa, M; Piroth, MD; Treusacher, P1
Hsu, IC; Inoue, T; Lessard, E; Pouliot, J; Shiomi, H; Sumida, I; Yoshioka, Y1
Akimoto, T; Katoh, H; Kitamoto, Y; Nakano, T; Shioya, M; Shirai, K1
Baltas, D; Giannouli, S; Lymperopoulou, G; Milickovic, N; Papagiannis, P; Sakelliou, L1
Komatsu, K; Koshida, K; Mizokami, A; Namiki, M; Shigehara, K1
Maloney, KE; Moul, JW; Sevilla, DW; Tseng, TY1
Dokiya, T; Momma, T; Murai, M; Saito, S; Toya, K; Yorozu, A1
Akimoto, T; Harada, K; Katoh, H; Kitamoto, Y; Nakano, T; Shirai, K; Tamaki, T1
Inoue, T; Isohashi, F; Kato, M; Kawaguchi, Y; Konishi, K; Nakamura, S; Oh, RJ; Shiomi, H; Sumida, I; Suzuki, O; Tanaka, E; Yoshioka, Y1
Coppens, L; de Leval, J; Deneufbourg, JM; Jansen, N; Nickers, P1
Dobbins, T; Fogarty, GB; Haddad, RL; Izard, MA; Katelaris, P; Rinks, A1
Bownes, P; Bryant, L; Bullard, J; Chin, YS; Hoskin, PJ; Ostler, P1
Albertsson, P; Edgren, M; Ekelund, AM; Lennernäs, B; Levitt, S; Lundberg, LM; Nilsson, S; Ullen, A1
Buron, C; Chauveinc, L; Cosset, JM; Delannes, M; Flam, T; Guerif, S; Le Vu, B; Livartowski, A; Peiffert, D; Pommier, P; Salem, N1
Chaswal, V; Henderson, DL; Thomadsen, BR; Yoo, S1
Chang, TC; Hanyu, N; Karasawa, K; Kuga, G; Yoshida, D1
Castellanos, E; Cohn-Cedermark, G; Fowler, J; Hellström, M; Kälkner, KM; Levitt, S; Lundell, M; Nilsson, J; Nilsson, S; Ryberg, M; Wahlgren, T; Zimmerman, R1
Edmundson, G; Gonzalez, J; Gustafson, G; Hollander, J; Martinez, A; Ohanian, N; Spencer, W; Stromberg, J; Vicini, F; Yan, Di1
Court, B; Gerbaulet, A; Haie-Meder, C; Lartigau, E; Perrin, JL; Wibault, P1
Flamant, F; Gerbaulet, A; Gruner, M; Habrand, JL; Haie-Meder, C; Martelli, H; Revillon, Y; Terrier-Lacombe, MJ; Valayer, J1
Bagshaw, MA; Ben-Yosef, R; Fessenden, P; Goffinet, DR; Kapp, DS; Prionas, SD1
Benson, R; Brabbins, D; Diokno, A; Edmundson, G; Garton, G; Gonzalez, J; Martinez, A; Schray, M; Stromberg, J; Zincke, H1
Forman, JD; Porter, AT1
Yu, Y1
Hahn, EW; Hildenbrand, D; Peschke, P; Wolber, G; Zuna, I1
Feldmann, HJ; Hartung, R; Hofmann, R; Kneschaurek, P; Molls, M; Paul, R; Schwarzer, JU; Stepan, R1
Aldenborg, F; Borghede, G; Hedelin, H; Holmäng, S; Johansson, KA; Mercke, C; Pettersson, S; Sernbo, G; Wallgren, A1
Borghede, G; Hedelin, H; Holmäng, S; Johansson, KA; Mercke, C; Sernbo, G1
Budach, V; Dinges, S; Loening, SA1
Budach, V; Deger, S; Dinges, S; Hinkelbein, W; Loening, SA; Roigas, J; Schnorr, D; Turk, I1
Gottesman, JE; Gribble, M; Hatton, J; Mate, TP; Van Hollebeke, L1
Boehmer, D; Budach, V; Deger, S; Dietel, M; Dinges, S; Hinkelbein, W; Koswig, S; Loening, SA; Schnorr, D; Wiegel, T1
Andreopoulos, D; Krenkel, B; Piatkowiak, M; Schleicher, UM; Wolff, JM1
Beauduin, M; Coppers, L; Darimont, M; de Leval, J; Deneufbourg, J; Nickers, P1
Amols, HI; Cohen, GN; Zaider, M1
Albert, A; Beauduin, M; Coppens, L; de Leval, J; Deneufbourg, JM; Nickers, P; Sabatier, J1
Dokiya, T; Momma, T; Murai, M; Saito, S1
Inomata, T; Inoue, K; Inoue, Y; Karashima, T; Kariya, S; Kasahara, K; Shuin, T; Yoshida, S2
Austin, PA; Baghdassarian, R; Cherlow, JM; Espinoza-Ferrel, T; Ingram, JE; Londrc, A; Perley, JE; Perley, JM; Puthawala, AA; Sawyer, DE; Shanberg, AM; Syed, AM; Wachs, BH1
Furihata, M; Inoue, K; Kariya, S; Kasahara, K; Shuin, T; Taguchi, T; Yoshida, S1
Armour, EP; Brenner, DJ; Edmundson, GK; Martinez, AA; Mitchell, C; Thames, HD1
Marinelli, D; Puthawala, A; Sawyer, DE; Shanberg, AM; Syed, N; Tansey, LA1
Bush, S; Khan, K; Stidley, C; Thompson, W1
Austin, P; Baghdassarian, R; Cherlow, J; Perley, J; Puthawala, A; Sawyer, D; Shanberg, A; Syed, AM; Tansey, L; Wachs, B1
Braun, J; Hofmann, R; Kneschaurek, P; Lindner, A; Lukas, P; Schwarzer, JU1
Donnelly, BJ; McPhee, MS; Pedersen, JE; Porter, AT1
Bagshaw, MA; Cox, RS; Freiha, F; Goffinet, DR; Kapp, DS; Prionas, SD1
Brosman, SA1
Porter, AT1
Porter, AT; Scrimger, JW1
Benson, RC; Brindle, JS; Diokno, A; Edmundson, G; Gonzalez, J; Martinez, A; Schray, M; Zincke, H1
Bertermann, H1
Ali, MM; Hackler, RH; Klein, FA; Marks, SE1
Pocha, JS; Porter, AT; Scrimger, JW1
De Laroche, G; Gerard, JP; Koonsilin, L; Mornex, F; Romestaing, P1

Reviews

12 review(s) available for iridium radioisotopes and Cancer of Prostate

ArticleYear
[Development and perspectives of brachytherapy in France].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2013, Volume: 17, Issue:2

    Topics: Brachytherapy; Cancer Care Facilities; Cesium Radioisotopes; Female; Forecasting; France; Health Services Accessibility; Hospitals, Military; Hospitals, Public; Hospitals, University; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Neoplasms; Practice Patterns, Physicians'; Prostatic Neoplasms; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Vaginal Neoplasms

2013
High-dose-rate brachytherapy in the curative treatment of patients with localized prostate cancer.
    Mayo Clinic proceedings, 2008, Volume: 83, Issue:12

    Topics: Brachytherapy; Dose Fractionation, Radiation; Humans; Iridium Radioisotopes; Male; Patient Selection; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Treatment Outcome

2008
[Brachytherapy in paediatric sarcoma].
    Bulletin du cancer, 2011, Volume: 98, Issue:5

    Topics: Brachytherapy; Child; Female; Genital Neoplasms, Female; Humans; Iridium Radioisotopes; Male; Models, Anatomic; Prostatic Neoplasms; Radiotherapy Dosage; Rhabdomyosarcoma; Sarcoma; Sex Factors; Urinary Bladder Neoplasms; Vaginal Neoplasms

2011
[Brachytherapy for prostate neoplasms].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 11

    Topics: Brachytherapy; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms; Radiotherapy Dosage; Treatment Outcome

2002
[Advances in brachytherapy--focusing on the permanent implant for early prostate carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:13

    Topics: Brachytherapy; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms; Radiotherapy Dosage; Relative Biological Effectiveness

2003
Fertility after prostate brachytherapy.
    BJU international, 2005, Volume: 96, Issue:6

    Topics: Brachytherapy; Fertility; Humans; Iridium Radioisotopes; Male; Postoperative Period; Prostatic Neoplasms; Radiotherapy Dosage

2005
[Brachytherapy in prostatic adenocarcinoma].
    Annales d'urologie, 1994, Volume: 28, Issue:6-7

    Topics: Adenocarcinoma; Brachytherapy; Combined Modality Therapy; Gold Radioisotopes; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Lymph Node Excision; Male; Prognosis; Prostatic Neoplasms; Survival Rate

1994
Prostate brachytherapy. An overview.
    Cancer, 1993, Feb-01, Volume: 71, Issue:3 Suppl

    Topics: Brachytherapy; Gold Radioisotopes; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Ytterbium

1993
[Combined iridium 192 afterloading therapy of prostate carcinoma].
    Praxis, 1997, Nov-26, Volume: 86, Issue:48

    Topics: Brachytherapy; Combined Modality Therapy; Humans; Iridium Radioisotopes; Male; Neoplasm Staging; Prognosis; Prostate; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies

1997
Followup prostate biopsy in patients with carcinoma of the prostate treated by 192iridium template irradiation plus supplemental external beam radiation.
    The Journal of urology, 1992, Volume: 147, Issue:3 Pt 2

    Topics: Aged; Biopsy; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prostate; Prostatic Neoplasms; Radiotherapy

1992
Is radiotherapy of use in stage C prostate cancer?
    Progress in clinical and biological research, 1989, Volume: 303

    Topics: Brachytherapy; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms

1989
Remote afterloading in prostatic cancer.
    Progress in clinical and biological research, 1989, Volume: 303

    Topics: Brachytherapy; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Prostatic Neoplasms

1989

Trials

26 trial(s) available for iridium radioisotopes and Cancer of Prostate

ArticleYear
Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020, Volume: 146

    Topics: Brachytherapy; Humans; Iridium Radioisotopes; Male; Neoplasm Recurrence, Local; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage

2020
Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate.
    International journal of radiation oncology, biology, physics, 2017, 09-01, Volume: 99, Issue:1

    Topics: Brachytherapy; Cause of Death; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Neoplasms, Second Primary; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Analysis; Time Factors; Treatment Outcome

2017
[Complications and effectiveness of treatment of patients with locally advanced prostate cancer after combined radiotherapy and radical prostatectomy with postoperative radiotherapy].
    Voprosy onkologii, 2015, Volume: 61, Issue:1

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Erectile Dysfunction; Humans; Incidence; Intraoperative Period; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Postoperative Period; Prostatectomy; Prostatic Neoplasms; Radiotherapy, Adjuvant; Russia; Treatment Outcome; Urinary Incontinence

2015
Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy.
    International journal of radiation oncology, biology, physics, 2017, 01-01, Volume: 97, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Grading; Non-Randomized Controlled Trials as Topic; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Risk; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Urination Disorders

2017
High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer.
    American journal of clinical oncology, 2010, Volume: 33, Issue:5

    Topics: Aged; Brachytherapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy, Intensity-Modulated; Survival Analysis; Treatment Outcome

2010
Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy.
    International journal of radiation oncology, biology, physics, 2011, Feb-01, Volume: 79, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alpha Particles; Beta Particles; Brachytherapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Risk

2011
High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence.
    International journal of radiation oncology, biology, physics, 2012, Mar-15, Volume: 82, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Brachytherapy; Dose Fractionation, Radiation; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Organs at Risk; Prostate-Specific Antigen; Prostatic Neoplasms; Rectum; Urethra

2012
Patient positioning based on a radioactive tracer implanted in patients with localized prostate cancer: a performance and safety evaluation.
    International journal of radiation oncology, biology, physics, 2013, Feb-01, Volume: 85, Issue:2

    Topics: Fiducial Markers; Gold; Humans; Iridium Radioisotopes; Male; Movement; Patient Positioning; Prostatic Neoplasms; Radionuclide Imaging; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided

2013
Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.
    The Journal of urology, 2003, Volume: 169, Issue:3

    Topics: Actuarial Analysis; Adenocarcinoma; Aged; Aged, 80 and over; Brachytherapy; Disease-Free Survival; Humans; Iridium Radioisotopes; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Survival Rate

2003
High-dose rate iridium-192 brachytherapy and external beam radiation therapy for prostate cancer with or without androgen ablation.
    International journal of urology : official journal of the Japanese Urological Association, 2004, Volume: 11, Issue:3

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Feasibility Studies; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radiotherapy Dosage

2004
High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Urology, 2004, Volume: 64, Issue:3

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Brachytherapy; Combined Modality Therapy; Cystitis; Disease-Free Survival; Dose Fractionation, Radiation; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Proctitis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, High-Energy; Treatment Outcome

2004
Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system?
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2005, Volume: 74, Issue:2

    Topics: Adenocarcinoma; Brachytherapy; Dose Fractionation, Radiation; Humans; Imaging, Three-Dimensional; Iridium Radioisotopes; Male; Patient Care Planning; Prostatic Neoplasms; Radiation Injuries; Radiometry; Tomography, X-Ray Computed; Treatment Outcome

2005
Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2006, Volume: 78, Issue:1

    Topics: Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Dose-Response Relationship, Radiation; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Dosage; Rectum; Surveys and Questionnaires; Urethra

2006
Four year clinical statistics of iridium-192 high dose rate brachytherapy.
    International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Brachytherapy; Disease-Free Survival; Humans; Iridium Radioisotopes; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Radiotherapy Dosage; Survival Rate; Time Factors

2006
192Ir low dose rate brachytherapy for boosting locally advanced prostate cancers after external beam radiotherapy: a phase II trial.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2006, Volume: 79, Issue:3

    Topics: Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Disease Progression; Dose-Response Relationship, Radiation; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Treatment Outcome

2006
High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2006, Volume: 18, Issue:6

    Topics: Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Dose-Response Relationship, Radiation; Feasibility Studies; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome

2006
Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study.
    International journal of radiation oncology, biology, physics, 2007, Mar-01, Volume: 67, Issue:3

    Topics: Aged; Analysis of Variance; Brachytherapy; Fecal Incontinence; France; Gastrointestinal Hemorrhage; Health Care Costs; Health Status; Hospitalization; Humans; Iridium Radioisotopes; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Quality of Life; Surveys and Questionnaires; Urination Disorders

2007
Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
    Acta oncologica (Stockholm, Sweden), 2007, Volume: 46, Issue:7

    Topics: Adenocarcinoma; Aged; Brachytherapy; Disease-Free Survival; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Treatment Outcome

2007
Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.
    International journal of radiation oncology, biology, physics, 1995, Aug-30, Volume: 33, Issue:1

    Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Ultrasonography, Interventional

1995
Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate.
    International journal of radiation oncology, biology, physics, 1994, Jan-01, Volume: 28, Issue:1

    Topics: Adenocarcinoma; Aged; Brachytherapy; Combined Modality Therapy; Hot Temperature; Humans; Hyperthermia, Induced; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Prostheses and Implants; Retrospective Studies; Thermometers

1994
Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
    International journal of radiation oncology, biology, physics, 1994, Jan-01, Volume: 28, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Prostatic Neoplasms; Survival Analysis; Survival Rate

1994
Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1997, Volume: 44, Issue:3

    Topics: Aged; Brachytherapy; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Penile Erection; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Treatment Outcome; Urination Disorders

1997
High-dose rate iridium192 afterloading therapy in combination with external beam irradiation for localized prostate cancer.
    Techniques in urology, 1997,Winter, Volume: 3, Issue:4

    Topics: Adenocarcinoma; Aged; Brachytherapy; Carcinoma in Situ; Combined Modality Therapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radiation Dosage; Treatment Outcome

1997
High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1998, Volume: 48, Issue:2

    Topics: Adenocarcinoma; Aged; Biopsy; Brachytherapy; Colitis, Ulcerative; Colostomy; Diabetes Complications; Feasibility Studies; Fistula; Follow-Up Studies; Humans; Iridium Radioisotopes; Laparoscopy; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Fistula; Risk Factors; Urethral Diseases

1998
Brachytherapy for prostate cancer in Japan.
    International journal of urology : official journal of the Japanese Urological Association, 2001, Volume: 8, Issue:7

    Topics: Aged; Aged, 80 and over; Brachytherapy; Humans; Iridium Radioisotopes; Japan; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Survival Analysis; Treatment Outcome

2001
Early reduction in the aneuploidy at chromosomes 7 and 8 are significantly correlated with clinical effect in high-dose rate brachytherapy with external beam radiotherapy in localized prostate cancer.
    International journal of molecular medicine, 2001, Volume: 8, Issue:6

    Topics: Aged; Aged, 80 and over; Aneuploidy; Brachytherapy; Chromosomes, Human, Pair 7; Chromosomes, Human, Pair 8; Dose-Response Relationship, Radiation; Humans; In Situ Hybridization, Fluorescence; Iridium Radioisotopes; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Treatment Outcome

2001

Other Studies

82 other study(ies) available for iridium radioisotopes and Cancer of Prostate

ArticleYear
Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
    Medical physics, 2023, Volume: 50, Issue:10

    Topics: Brachytherapy; Catheters; Humans; Iridium Radioisotopes; Male; Prostate; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies

2023
Methodology of dose calculation for external beam radiation combined with high dose rate brachytherapy in the era of 3-dimensional treatment planning system.
    Medicine, 2020, Jul-17, Volume: 99, Issue:29

    Topics: Algorithms; Brachytherapy; Carcinoma; Dose Fractionation, Radiation; Female; Humans; Iridium Radioisotopes; Male; Nasopharyngeal Neoplasms; Prostatic Neoplasms; Radiation Dosage; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Uterine Cervical Neoplasms

2020
Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue.
    Radiation and environmental biophysics, 2018, Volume: 57, Issue:3

    Topics: Dose-Response Relationship, Radiation; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms; Proteomics; Radiometry; Transcription, Genetic

2018
RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning.
    International journal of radiation oncology, biology, physics, 2020, 11-01, Volume: 108, Issue:3

    Topics: Brachytherapy; Colon, Sigmoid; Deep Learning; Female; Humans; Iridium Radioisotopes; Male; Monte Carlo Method; Neural Networks, Computer; Organs at Risk; Prostate; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Retrospective Studies; Urinary Bladder; Uterine Cervical Neoplasms

2020
HDR brachytherapy in vivo source position verification using a 2D diode array: A Monte Carlo study.
    Journal of applied clinical medical physics, 2018, Volume: 19, Issue:4

    Topics: Brachytherapy; Humans; Iridium Radioisotopes; Male; Monte Carlo Method; Phantoms, Imaging; Prostatic Neoplasms; Radiotherapy Dosage

2018
Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2019, Volume: 195, Issue:5

    Topics: Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Risk Factors

2019
An analytical model to determine interseed attenuation effect in low-dose-rate brachytherapy.
    Journal of applied clinical medical physics, 2013, May-06, Volume: 14, Issue:3

    Topics: Algorithms; Brachytherapy; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Models, Theoretical; Monte Carlo Method; Phantoms, Imaging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted

2013
High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 110, Issue:2

    Topics: Aged; Brachytherapy; Dose-Response Relationship, Radiation; Gastrointestinal Diseases; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radiation Injuries; Rectum; Urethra; Urologic Diseases

2014
Interstitial rotating shield brachytherapy for prostate cancer.
    Medical physics, 2014, Volume: 41, Issue:5

    Topics: Brachytherapy; Catheters; Equipment Design; Gadolinium; Humans; Iridium Radioisotopes; Male; Monte Carlo Method; Needles; Nickel; Platinum Compounds; Prostatic Neoplasms; Radiation Protection; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Time Factors; Titanium; Urethra; Urinary Bladder

2014
External beam radiotherapy plus single-fraction high dose rate brachytherapy in the treatment of locally advanced prostate cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 112, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Cohort Studies; Dose Fractionation, Radiation; Humans; Iridium Radioisotopes; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Survival Rate; Treatment Outcome

2014
Dosimetric analysis of urethral strictures following HDR (192)Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 113, Issue:3

    Topics: Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms; Radiometry; Radiotherapy Dosage; Urethra; Urethral Stricture

2014
[High-dose brachytherapy for prostate cancer in real time using 192-IR (specifics of dosimetric planning)].
    Voprosy onkologii, 2015, Volume: 61, Issue:1

    Topics: Aged; Brachytherapy; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Treatment Outcome

2015
A method for verification of treatment delivery in HDR prostate brachytherapy using a flat panel detector for both imaging and source tracking.
    Medical physics, 2016, Volume: 43, Issue:5

    Topics: Brachytherapy; Catheters; Equipment Design; Fiducial Markers; Humans; Iridium Radioisotopes; Male; Models, Anatomic; Phantoms, Imaging; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Water

2016
Monte Carlo study of the impact of a magnetic field on the dose distribution in MRI-guided HDR brachytherapy using Ir-192.
    Physics in medicine and biology, 2016, 09-21, Volume: 61, Issue:18

    Topics: Brachytherapy; Computer Simulation; Humans; Iridium Radioisotopes; Magnetic Fields; Magnetic Resonance Imaging; Male; Monte Carlo Method; Phantoms, Imaging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Image-Guided; Software

2016
Clinical application of the Fricke-glucomannan gel dosimeter for high-dose-rate (192)Ir brachytherapy.
    Physics in medicine and biology, 2008, Jul-21, Volume: 53, Issue:14

    Topics: Absorption; Brachytherapy; Calibration; Gels; Humans; Iridium Radioisotopes; Magnetic Resonance Imaging; Male; Mannans; Prostatic Neoplasms; Radiometry; Radiotherapy Dosage; Reproducibility of Results; Thermoluminescent Dosimetry

2008
Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:7

    Topics: Aged; Brachytherapy; Disease-Free Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Gastrointestinal Diseases; Humans; Iridium Radioisotopes; Male; Male Urogenital Diseases; Proportional Hazards Models; Prostatic Neoplasms; Radiotherapy; Radiotherapy, Conformal; Retrospective Studies

2008
Intrafraction motion of the prostate during an IMRT session: a fiducial-based 3D measurement with Cone-beam CT.
    Radiation oncology (London, England), 2008, Nov-05, Volume: 3

    Topics: Brachytherapy; Cone-Beam Computed Tomography; Dose Fractionation, Radiation; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Iridium Radioisotopes; Male; Motion; Prostatic Neoplasms; Radiation Oncology; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Reproducibility of Results; Treatment Outcome

2008
Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients.
    International journal of radiation oncology, biology, physics, 2009, Aug-01, Volume: 74, Issue:5

    Topics: Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Humans; Iridium Radioisotopes; Male; Predictive Value of Tests; Prostatic Neoplasms; Radiation Tolerance; Radiotherapy; Regression Analysis; T-Lymphocytes, Cytotoxic

2009
Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy
    International journal of radiation oncology, biology, physics, 2009, Sep-01, Volume: 75, Issue:1

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Androgen Antagonists; Brachytherapy; Flutamide; Humans; Iridium Radioisotopes; Male; Middle Aged; Pilot Projects; Prostatic Neoplasms; Radiation Injuries; Radiography; Radiotherapy; Radiotherapy Dosage; Rectum; Regression Analysis; Relative Biological Effectiveness; Tumor Burden; Urethra; Urogenital System

2009
Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
    International journal of radiation oncology, biology, physics, 2009, Nov-01, Volume: 75, Issue:3

    Topics: Aged; Androgen Antagonists; Brachytherapy; Disease-Free Survival; Dose Fractionation, Radiation; Feasibility Studies; Humans; Iridium Radioisotopes; Magnetic Resonance Imaging, Interventional; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Pilot Projects; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Conformal; Urination Disorders

2009
In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
    Physics in medicine and biology, 2009, May-07, Volume: 54, Issue:9

    Topics: Alanine; Brachytherapy; Electron Spin Resonance Spectroscopy; Humans; Iridium Radioisotopes; Male; Phantoms, Imaging; Prostatic Neoplasms; Radiation Dosage; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Uncertainty; Urethra

2009
Clinical results of iridium-192 high dose rate brachytherapy with external beam radiotherapy.
    Japanese journal of clinical oncology, 2010, Volume: 40, Issue:7

    Topics: Aged; Aged, 80 and over; Brachytherapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radioisotope Teletherapy; Radiotherapy Dosage; Treatment Outcome

2010
Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate.
    International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Brachytherapy; Disease-Free Survival; Dose Fractionation, Radiation; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Incidence; Iridium Radioisotopes; Male; Middle Aged; Needles; Prostatic Neoplasms; Radiation Injuries; Radiography; Rectum; Relative Biological Effectiveness; Risk Factors; Time Factors; Tumor Burden

2012
Evaluation of linear array MOSFET detectors for in vivo dosimetry to measure rectal dose in HDR brachytherapy.
    Australasian physical & engineering sciences in medicine, 2011, Volume: 34, Issue:3

    Topics: Body Burden; Brachytherapy; Calibration; Equipment Design; Feasibility Studies; Female; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms; Quality Assurance, Health Care; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Reproducibility of Results; Transistors, Electronic; Uterine Cervical Neoplasms

2011
In vivo assessment of catheter positioning accuracy and prolonged irradiation time on liver tolerance dose after single-fraction 192Ir high-dose-rate brachytherapy.
    Radiation oncology (London, England), 2011, Sep-05, Volume: 6

    Topics: Brachytherapy; Catheterization; Humans; Image Processing, Computer-Assisted; Iridium Radioisotopes; Liver; Magnetic Resonance Imaging; Male; Models, Statistical; Neoplasms; Prostatic Neoplasms; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Retrospective Studies; Time Factors; Tomography, X-Ray Computed

2011
Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.
    BJU international, 2012, Volume: 109, Issue:6

    Topics: Aged; Aged, 80 and over; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiotherapy Dosage; Salvage Therapy; Treatment Outcome

2012
Implementation of high-dose-rate brachytherapy and androgen deprivation in patients with prostate cancer.
    International journal of radiation oncology, biology, physics, 2012, Jul-01, Volume: 83, Issue:3

    Topics: Aged; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Compartment Syndromes; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Grading; Neoplasms, Second Primary; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Conformal; Treatment Outcome; Urination Disorders

2012
Solid state TL detectors for in vivo dosimetry in brachytherapy.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2012, Volume: 71 Suppl

    Topics: Brachytherapy; Calibration; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Thermoluminescent Dosimetry

2012
Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy.
    Radiation oncology (London, England), 2012, Dec-10, Volume: 7

    Topics: Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Disease Progression; Follow-Up Studies; Hormones; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies

2012
Gadolinium-153 as a brachytherapy isotope.
    Physics in medicine and biology, 2013, Feb-21, Volume: 58, Issue:4

    Topics: Anisotropy; Brachytherapy; Equipment Design; Gadolinium; Humans; Iridium Radioisotopes; Male; Monte Carlo Method; Photons; Prostatic Neoplasms; Radiation Protection; Radioisotopes; Radiotherapy Dosage; Scattering, Radiation

2013
Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2002, Volume: 178, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Breast Neoplasms; Bronchial Neoplasms; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Kidney Neoplasms; Male; Middle Aged; Palliative Care; Prostatic Neoplasms; Radiotherapy Dosage; Rectal Neoplasms; Sigmoid Neoplasms; Time Factors; Tongue Neoplasms; Tonsillar Neoplasms; Urinary Bladder Neoplasms; Uterine Neoplasms

2002
Treatment of localized prostate cancer using a combination of high dose rate Iridium-192 brachytherapy and external beam irradiation: initial Australian experience.
    Australasian radiology, 2003, Volume: 47, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Treatment Outcome

2003
3D dose verification in 192Ir HDR prostate monotherapy using polymer gels and MRI.
    Medical physics, 2003, Volume: 30, Issue:8

    Topics: Algorithms; Brachytherapy; Calibration; Dose-Response Relationship, Radiation; Gels; Glass; Humans; Imaging, Three-Dimensional; Iridium Radioisotopes; Magnetic Resonance Imaging; Male; Phantoms, Imaging; Polymers; Prostatic Neoplasms; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed

2003
In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer.
    International journal of radiation oncology, biology, physics, 2003, Nov-15, Volume: 57, Issue:4

    Topics: Brachytherapy; Calibration; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Thermoluminescent Dosimetry; Tomography, X-Ray Computed

2003
The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States.
    Cancer, 2003, Nov-01, Volume: 98, Issue:9

    Topics: Adenocarcinoma; Aged; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal

2003
Is an 192Ir permanent seed implant feasible for prostate brachytherapy?
    Brachytherapy, 2002, Volume: 1, Issue:4

    Topics: Brachytherapy; Costs and Cost Analysis; Family Health; Feasibility Studies; Humans; Iridium Radioisotopes; Male; Occupational Exposure; Prostatic Neoplasms; Radiobiology; Radiology; Radiotherapy Dosage

2002
Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    International journal of radiation oncology, biology, physics, 2004, Jul-01, Volume: 59, Issue:3

    Topics: Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Conformal; Rectum; Urinary Bladder

2004
In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191).
    International journal of radiation oncology, biology, physics, 2004, Jul-01, Volume: 59, Issue:3

    Topics: Brachytherapy; Copper; Humans; Iridium Radioisotopes; Lithium Compounds; Magnesium; Male; Phosphorus; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Thermoluminescent Dosimetry

2004
Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
    International journal of radiation oncology, biology, physics, 2004, Sep-01, Volume: 60, Issue:1

    Topics: Aged; Brachytherapy; Health Status; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Prostatic Neoplasms; Quality of Life; Radiotherapy Dosage; Radiotherapy, Conformal; Surveys and Questionnaires

2004
Selective identification of different brachytherapy sources, ferromagnetic seeds, and fiducials in the prostate using an automated seed sorting algorithm.
    Brachytherapy, 2004, Volume: 3, Issue:2

    Topics: Aged; Algorithms; Brachytherapy; Ferric Compounds; Humans; Iridium Radioisotopes; Male; Palladium; Pelvis; Prostate; Prostatic Neoplasms; Radioisotopes; Salvage Therapy; Tomography, X-Ray Computed

2004
Dosimetric characterization of radioactive sources employed in prostate cancer therapy.
    Brachytherapy, 2004, Volume: 3, Issue:4

    Topics: Brachytherapy; Computer Simulation; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy, Computer-Assisted

2004
[The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2004, Volume: 8 Suppl 1

    Topics: Adult; Brachytherapy; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Injuries; Radiation Protection; Radioisotopes; Radiotherapy Dosage

2004
GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2005, Volume: 74, Issue:2

    Topics: Brachytherapy; Contraindications; Dose Fractionation, Radiation; Humans; Iridium Radioisotopes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Patient Selection; Prostatic Neoplasms; Radiation Injuries; Rectum; Salvage Therapy; Ultrasonography

2005
Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy
    International journal of radiation oncology, biology, physics, 2005, Oct-01, Volume: 63, Issue:2

    Topics: Aged; Brachytherapy; Dose Fractionation, Radiation; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radiation Injuries; Severity of Illness Index; Urethra; Urinary Bladder; Urination Disorders

2005
Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genito
    International journal of radiation oncology, biology, physics, 2005, Oct-01, Volume: 63, Issue:2

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Brachytherapy; Combined Modality Therapy; Dose Fractionation, Radiation; Feasibility Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radiation Injuries; Urethra; Urination Disorders

2005
192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2006, Volume: 78, Issue:1

    Topics: Adenocarcinoma; Brachytherapy; Combined Modality Therapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Computer-Assisted

2006
Optimization of dose distribution for HDR brachytherapy of the prostate using Attraction-Repulsion Model.
    International journal of radiation oncology, biology, physics, 2006, Feb-01, Volume: 64, Issue:2

    Topics: Algorithms; Brachytherapy; Humans; Iridium Radioisotopes; Male; Prostate; Prostatic Neoplasms; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Urethra; Urinary Bladder

2006
Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization
    International journal of radiation oncology, biology, physics, 2006, Apr-01, Volume: 64, Issue:5

    Topics: Aged; Aged, 80 and over; Brachytherapy; Dose Fractionation, Radiation; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostate; Prostatic Neoplasms; Radiation Injuries; Radiography; Radiotherapy, Conformal; Rectum; Urethra; Urogenital System

2006
A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy.
    Medical physics, 2005, Volume: 32, Issue:12

    Topics: Biophysical Phenomena; Biophysics; Brachytherapy; Computer Simulation; Humans; Iridium Radioisotopes; Male; Monte Carlo Method; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Ytterbium

2005
Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report.
    Prostate cancer and prostatic diseases, 2006, Volume: 9, Issue:2

    Topics: Adenocarcinoma; Aged; Biopsy, Needle; Brachytherapy; Carcinosarcoma; Combined Modality Therapy; Follow-Up Studies; Humans; Immunohistochemistry; Iridium Radioisotopes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Pelvic Exenteration; Prostate-Specific Antigen; Prostatic Neoplasms; Rectal Neoplasms; Time Factors; Treatment Outcome

2006
Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Retrospective Studies; Treatment Outcome

2006
Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.
    International journal of radiation oncology, biology, physics, 2006, Jun-01, Volume: 65, Issue:2

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Brachytherapy; Dose Fractionation, Radiation; Gastrointestinal Hemorrhage; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radiation Injuries; Rectal Diseases; Rectum

2006
High-dose-rate brachytherapy combined with long-term hormonal therapy for high-risk prostate cancer: results of a retrospective analysis.
    Radiation medicine, 2006, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Dose Fractionation, Radiation; Gonadotropin-Releasing Hormone; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Retrospective Studies; Survival Rate; Treatment Outcome

2006
Six year experience of external beam radiotherapy, brachytherapy boost with a 1Ci (192)Ir source, and neoadjuvant hormonal manipulation for prostate cancer.
    International journal of radiation oncology, biology, physics, 2006, Sep-01, Volume: 66, Issue:1

    Topics: Aged; Aged, 80 and over; Brachytherapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoadjuvant Therapy; Proctitis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Survival Analysis; Time Factors; Treatment Failure; Urogenital System

2006
High dose-rate brachytherapy of prostate cancer utilising Iridium-192 after-loading technique: technical and methodological aspects.
    International journal of oncology, 2006, Volume: 29, Issue:6

    Topics: Brachytherapy; Humans; Iridium Radioisotopes; Male; Prostate; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Urethra

2006
Multi-species prostate implant treatment plans incorporating 192Ir and 125I using a Greedy Heuristic based 3D optimization algorithm.
    Medical physics, 2007, Volume: 34, Issue:2

    Topics: Algorithms; Combined Modality Therapy; Computer Simulation; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Models, Biological; Prostatic Neoplasms; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted

2007
[How to select the treatment options in prostate cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:7

    Topics: Brachytherapy; Combined Modality Therapy; Dose Fractionation, Radiation; Humans; Informed Consent; Iodine Radioisotopes; Iridium Radioisotopes; Male; Prostatic Neoplasms; Quality of Life; Radiotherapy Dosage; Radiotherapy, Conformal

2007
[The role of brachytherapy in the therapeutic strategy of vesico-prostatic rhabdomyosarcoma in children].
    Annales d'urologie, 1994, Volume: 28, Issue:6-7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Child; Child, Preschool; Combined Modality Therapy; Cystectomy; Humans; Infant; Iridium Radioisotopes; Male; Neoplasm Recurrence, Local; Prostatectomy; Prostatic Neoplasms; Radiotherapy Dosage; Rhabdomyosarcoma; Salvage Therapy; Survival Rate; Urinary Bladder Neoplasms

1994
A nondivergent specification of the mean treatment dose in interstitial brachytherapy.
    Medical physics, 1996, Volume: 23, Issue:6

    Topics: Biometry; Biophysical Phenomena; Biophysics; Brachytherapy; Humans; Iridium Radioisotopes; Male; Models, Biological; Prostatic Neoplasms; Radiotherapy Dosage

1996
Interstitial radiation and hyperthermia in the Dunning R3327 prostate tumour model: therapeutic efficacy depends on radiation dose-rate, sequence and frequency of heating.
    International journal of radiation biology, 1996, Volume: 70, Issue:5

    Topics: Animals; Combined Modality Therapy; Dose-Response Relationship, Radiation; Hyperthermia, Induced; Iridium Radioisotopes; Male; Prostatic Neoplasms; Radiotherapy Dosage; Rats; Rats, Inbred Strains; Survival Analysis; Time Factors

1996
Iridium 192 high-dose-rate brachytherapy--a useful alternative therapy for localized prostate cancer?
    World journal of urology, 1997, Volume: 15, Issue:4

    Topics: Adult; Aged; Brachytherapy; Carcinoma; Disease-Free Survival; Erectile Dysfunction; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Risk Factors; Survival Rate

1997
Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1997, Volume: 44, Issue:3

    Topics: Dose-Response Relationship, Radiation; Humans; Iridium Radioisotopes; Male; Prostate; Prostatic Neoplasms; Radiotherapy Dosage; Ultrasonography

1997
High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report.
    International journal of radiation oncology, biology, physics, 1998, Jun-01, Volume: 41, Issue:3

    Topics: Aged; Brachytherapy; Dose Fractionation, Radiation; Feasibility Studies; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Dosage

1998
[Combined treatment of localized prostate cancer with HDR-Iridium 192 remote brachytherapy and external beam irradiation].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1999, Volume: 175, Issue:8

    Topics: Aged; Aged, 80 and over; Brachytherapy; Disease-Free Survival; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiotherapy; Radiotherapy Dosage; Treatment Outcome

1999
Feasibility study combining low dose rate (192)Ir brachytherapy and external beam radiotherapy aiming at delivering 80-85 Gy to prostatic adenocarcinoma.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2000, Volume: 55, Issue:1

    Topics: Adenocarcinoma; Aged; Analysis of Variance; Antineoplastic Agents, Hormonal; Brachytherapy; Chemotherapy, Adjuvant; Chi-Square Distribution; Feasibility Studies; Follow-Up Studies; Humans; Intraoperative Care; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Pelvic Bones; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Rectum; Seminal Vesicles; Ultrasonography, Interventional; Urethra

2000
An independent dose-to-point calculation program for the verification of high-dose-rate brachytherapy treatment planning.
    International journal of radiation oncology, biology, physics, 2000, Nov-01, Volume: 48, Issue:4

    Topics: Algorithms; Brachytherapy; Humans; Iridium Radioisotopes; Male; Physical Phenomena; Physics; Prostatic Neoplasms; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Software; Tomography, X-Ray Computed

2000
PSA kinetics after external beam radiotherapy alone or combined with an iridium brachytherapy boost to deliver 85 grays to prostatic adenocarcinoma.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2001, Volume: 177, Issue:2

    Topics: Adenocarcinoma; Aged; Brachytherapy; Cohort Studies; Data Interpretation, Statistical; Follow-Up Studies; Humans; Immunoenzyme Techniques; Iridium Radioisotopes; Kinetics; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Retrospective Studies; Time Factors

2001
[High-dose rate Iridium-192 brachytherapy with flexible applicator--a trial toward decrease of stress during treatment and improvement of quality of life].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2001, Volume: 92, Issue:5

    Topics: Aged; Aged, 80 and over; Brachytherapy; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Radiotherapy Dosage; Stress, Psychological

2001
[High-dose rate iridium-192 brachytherapy combined with external beam radiotherapy for localized prostate cancer].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2001, Volume: 92, Issue:5

    Topics: Aged; Aged, 80 and over; Brachytherapy; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Radiotherapy Dosage

2001
Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy.
    Cancer, 2001, Oct-15, Volume: 92, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Humans; Iridium Radioisotopes; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Prostatectomy; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, High-Energy; Survival Analysis

2001
Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue.
    International journal of radiation oncology, biology, physics, 2002, Jan-01, Volume: 52, Issue:1

    Topics: Aged; Brachytherapy; Dose Fractionation, Radiation; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Poisson Distribution; Prospective Studies; Prostatic Neoplasms; Radiation Oncology; Radiotherapy, Conformal; Treatment Failure

2002
Transperineal percutaneous iridium-192 interstitial template implant of the prostate: results and complications in 321 patients.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Humans; Iridium Radioisotopes; Lymph Node Excision; Male; Middle Aged; Prostatic Neoplasms; Retrospective Studies; Survival Analysis; Survival Rate

1992
Temporary iridium-192 implant in the management of carcinoma of the prostate.
    Cancer, 1992, May-15, Volume: 69, Issue:10

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Brachytherapy; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Survival Analysis; Treatment Outcome

1992
[High-dose-rate brachytherapy of prostatic carcinoma with iridium 192].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1992, Volume: 168, Issue:1

    Topics: Aged; Brachytherapy; Carcinoma; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Computer-Assisted; Remission Induction

1992
Iridium-192 brachytherapy in the treatment of cancer of the prostate.
    The Urologic clinics of North America, 1991, Volume: 18, Issue:3

    Topics: Adenocarcinoma; Aged; Brachytherapy; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Radiography

1991
External beam irradiation combined with the use of 192-iridium implants and radiofrequency-induced hyperthermia in the treatment of prostatic carcinoma.
    Progress in clinical and biological research, 1991, Volume: 370

    Topics: Brachytherapy; Combined Modality Therapy; Humans; Hyperthermia, Induced; Iridium Radioisotopes; Male; Neoplasm Staging; Prostatic Neoplasms; Radiotherapy Dosage

1991
Iridium-192 implants in patients with large stage C prostate cancer.
    Progress in clinical and biological research, 1991, Volume: 370

    Topics: Bone Neoplasms; Brachytherapy; Combined Modality Therapy; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Male; Neoplasm Staging; Prostatic Neoplasms; Survival Rate

1991
Pelvic lymphadenectomy and transperineal interstitial implantation of IR 192 combined with external beam radiotherapy for bulky stage C prostatic carcinoma.
    International journal of radiation oncology, biology, physics, 1989, Volume: 17, Issue:5

    Topics: Adult; Aged; Brachytherapy; Combined Modality Therapy; Follow-Up Studies; Humans; Iridium Radioisotopes; Lymph Node Excision; Male; Middle Aged; Pelvis; Prostatic Neoplasms

1989
The European experience: use of transrectal ultrasound in the diagnosis and management of prostate cancer.
    Progress in clinical and biological research, 1987, Volume: 237

    Topics: Brachytherapy; Europe; History, 20th Century; Humans; Iridium Radioisotopes; Male; Palpation; Prostatic Neoplasms; Ultrasonography; Urology

1987
Bilateral pelvic lymphadenectomy, iridium 192 template, and external beam therapy for localized prostatic carcinoma: complications and results.
    Southern medical journal, 1988, Volume: 81, Issue:1

    Topics: Adenocarcinoma; Aged; Brachytherapy; Combined Modality Therapy; Humans; Iridium Radioisotopes; Lymph Node Excision; Male; Middle Aged; Pelvis; Postoperative Complications; Proctitis; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Dosage

1988
Remote interstitial afterloading in cancer of the prostate: preliminary experience with the MicroSelectron.
    International journal of radiation oncology, biology, physics, 1988, Volume: 14, Issue:3

    Topics: Brachytherapy; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms; Radiation Protection

1988
Curative treatment of carcinoma of the prostate with an association of external irradiation, iridium implant and lymphadenectomy.
    Progress in clinical and biological research, 1987, Volume: 243B

    Topics: Adenocarcinoma; Aged; Brachytherapy; Humans; Iridium Radioisotopes; Lymph Node Excision; Male; Prognosis; Prostatic Neoplasms

1987